JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 46:1076-1084, doi:10.1016/j.jacc.2005.05.073 (Published online 7 September 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2005.05.073v3
46/6/1076    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perugini, E.
Right arrow Articles by Rapezzi, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perugini, E.
Right arrow Articles by Rapezzi, C.

CLINICAL RESEARCH: CARDIAC IMAGING

Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99mTc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy

Enrica Perugini, MD*, Pier Luigi Guidalotti, MD{dagger}, Fabrizio Salvi, MD{ddagger}, Robin M.T. Cooke, MA*, Cinzia Pettinato, MD{dagger}, Letizia Riva, MD*, Ornella Leone, MD§, Mohsen Farsad, MD{dagger}, Paolo Ciliberti, MD*, Letizia Bacchi-Reggiani, MSc, MBiostat*, Francesco Fallani, MD*, Angelo Branzi, MD* and Claudio Rapezzi, MD*,*

* Institute of Cardiology, University of Bologna and S. Orsola-Malpighi Hospital, Bologna, Italy
{dagger} Nuclear Medicine Unit, University of Bologna and S. Orsola-Malpighi Hospital, Bologna, Italy
§ Department of Pathology, University of Bologna and S. Orsola-Malpighi Hospital, Bologna, Italy
{ddagger} Department of Neurology, Ospedale Bellaria, Bologna, Italy.

Manuscript received March 4, 2005; revised manuscript received May 18, 2005, accepted May 24, 2005.

* Reprint requests and correspondence: Prof. Claudio Rapezzi, Istituto di Cardiologia, Policlinico S. Orsola-Malpighi, via Massarenti 9, 40138 Bologna, Italy. (Email: crapezzi{at}aosp.bo.it).

OBJECTIVES: We investigated the diagnostic accuracy of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) scintigraphy for differentiation of monoclonal immunoglobulin light-chain (AL) and transthyretin (TTR)-related cardiac amyloidosis.

BACKGROUND: Differential diagnosis between TTR-related and AL amyloidosis is often complex and time-consuming.

METHODS: Patients under routine observation with TTR-related/AL systemic amyloidosis and echocardiographic evidence of cardiac involvement were studied with 99mTc-DPD scintigraphy.

RESULTS: Patients with cardiac involvement of TTR-related (group A; n = 15) and AL (group B; n = 10) etiology were comparable for left ventricular mass and renal function. Heart and heart/whole-body tracer retention were significantly higher (p < 0.05) in group A as compared with group B and with 10 unaffected controls. At visual scoring, cardiac 99mTc-DPD uptake was present in all group A patients and absent in all group B patients; thus, using genotyping/immunohistochemistry as the reference technique, the accuracy of 99mTc-DPD scintigraphy for distinction of TTR-related and AL etiology was 100%. Cardiac 99mTc-DPD uptake was also absent among unaffected controls. Using echocardiography as the reference standard for recognition of cardiac involvement, sensitivity and specificity of scintigraphy were both 100% for group A patients; in group B, sensitivity was 0% and specificity was 100% (accuracy, 50%). Eleven patients with myocardial 99mTc-DPD uptake underwent 99mTc-methylene diphosphonate (99mTc-MDP) scintigraphy; all patients showed a 99mTc-MDP myocardial visual score of 0.

CONCLUSIONS: Etiology is a third major cause—in addition to type of organ-involved (soft-tissue/heart) and tracer type—of scintigraphic variability in cardiac amyloidosis. This is a highly relevant consideration for future studies. We conclude that 99mTc-DPD scintigraphy is a useful step in the workup of the differential diagnosis of TTR versus AL etiology in patients with documented cardiac amyloidosis.

Abbreviations and Acronyms
  AL = monoclonal immunoglobulin light-chain
  CA = cardiac amyloidosis
  LV = left ventricle/ventricular
  OLT = orthotopic liver transplantation
  ROI = region of interest
  SPECT = single-photon emission computed tomography
  99mTc-DPD = 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid
  99mTc-MDP = 99mTc-methylene diphosphonate
  TTR = transthyretin




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
C. Rapezzi, P. Guidalotti, F. Salvi, L. Riva, and E. Perugini
Usefulness of 99mTc-DPD Scintigraphy in Cardiac Amyloidosis
J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1509 - 1510.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. B. Selvanayagam, P. N. Hawkins, and S. Neubauer
Reply
J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1510 - 1510.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
K. B. Shah, Y. Inoue, and M. R. Mehra
Amyloidosis and the heart: a comprehensive review.
Arch Intern Med, September 25, 2006; 166(17): 1805 - 1813.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.